No services found
No Products found
100ug, 1MG
IgG1, kappa
ProteoGenix
Primary Antibodies
Monoclonal Antibody
Mammalian cells
Elisa, WB
Modotuximab is investigated for the treatment of metastatic Colorectal Cancer (mCRC).
Immobilized EGFR / ERBB1 / HER1, C-His, recombinant protein (cat. No. PX-P5701) at 0.5µg/mL (100µL/well) can bind Modotuximab Biosimilar - Anti-EGFR, ERBB1 domain III mAb (cat. No. PX-TA1305) in indirect ELISA with Goat Anti-Human IgG secondary antibody coupled with HRP measured by OD450 giving an EC50 at 0.5282M.
Reviews
There are no reviews yet.
Your email address will not be published. Required fields are marked *
In which application did you use the antibody? * WB ELISA Sandwich ELISA IF IHC IP FC other
Did it work in your application? * Yes No
Your review *
Name *
Email *
Save my name, email, and website in this browser for the next time I comment.
Related products
Send us a message from the form below
First name
Last name
Email address
Lab / Company
Phone number
Message
send
Your cart is currently empty.